Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

27.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unbiased CRISPR synthetic lethal screening for genetic vulnerabilities in a succinate dehydrogenase-loss model of paraganglioma.

iScience·2026
Same author

Mini-Galaxy: Rethinking Complex Human Diseases Through the Lens of Systems Biology and Multilayered AI Network Perspectives.

International journal of molecular sciences·2026
Same author

A two-tier framework for responsible research on human embryo models.

Cell·2026
Same author

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Stem cell reports·2026
Same author

Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancer.

Science translational medicine·2026
Same author

Artificial Clinic Intelligence (ACI): A Generative AI-Powered Modeling Platform to Optimize Patient Cohort Enrichment and Clinical Trial Optimization.

Cancers·2025

Related Experiment Video

Updated: Dec 19, 2025

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

14.0K

Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells.

Wei Zhao1, Anhua Lei2, Lin Tian2

  • 1Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China; Zhejiang Provincial Key Lab of Ophthalmology, Eye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China; Institute of Hematology, Zhejiang University, Hangzhou 310058, China.

Iscience
|June 6, 2020
PubMed
Summary

Researchers are developing universal stem cells to overcome immune rejection in cell therapies. Genetically engineering these cells aims to reduce immunogenicity, paving the way for broader therapeutic applications.

Keywords:
Biological SciencesCell BiologyGenetic EngineeringStem Cells Research

More Related Videos

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids
10:52

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Published on: June 5, 2015

13.4K
Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

13.2K

Related Experiment Videos

Last Updated: Dec 19, 2025

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

14.0K
Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids
10:52

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Published on: June 5, 2015

13.4K
Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

13.2K

Area of Science:

  • Immunology
  • Regenerative Medicine
  • Genetic Engineering

Background:

  • Immunoincompatibility is a major hurdle for cell therapies, leading to rejection of allogeneic transplants.
  • Current methods involve genetically modifying patient cells, which is time-consuming and expensive.

Purpose of the Study:

  • To review strategies for reducing cell immunogenicity and overcoming immune rejection.
  • To explore the development of universal pluripotent stem cells for broader therapeutic use.
  • To summarize methods for evaluating hypoimmunogenicity in engineered cells.

Main Methods:

  • Summarizing current research on harnessing immunosuppressive mechanisms.
  • Reviewing studies on genetically modifying pluripotent stem cells to evade immune attack.
  • Compiling methods for assessing hypoimmunogenicity.

Main Results:

  • Progress has been made in reducing cell immunogenicity through genetic engineering.
  • Genetically modified pluripotent stem cells show promise in escaping immune attack.
  • Methods for evaluating hypoimmunogenicity are being refined.

Conclusions:

  • Developing universal pluripotent stem cells offers a promising alternative to patient-specific cell modifications.
  • Engineered universal stem cells could accelerate the clinical application of gene and cell therapies.
  • Further advancements hold potential for regenerative medicine.